WO2017140017A1 - Wound hemostatic device having repeated drug administration function - Google Patents

Wound hemostatic device having repeated drug administration function Download PDF

Info

Publication number
WO2017140017A1
WO2017140017A1 PCT/CN2016/078241 CN2016078241W WO2017140017A1 WO 2017140017 A1 WO2017140017 A1 WO 2017140017A1 CN 2016078241 W CN2016078241 W CN 2016078241W WO 2017140017 A1 WO2017140017 A1 WO 2017140017A1
Authority
WO
WIPO (PCT)
Prior art keywords
hemostatic agent
hemostatic
wound
tube
agent
Prior art date
Application number
PCT/CN2016/078241
Other languages
French (fr)
Chinese (zh)
Inventor
张贯京
陈兴明
葛新科
Original Assignee
深圳市圣必智科技开发有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳市圣必智科技开发有限公司 filed Critical 深圳市圣必智科技开发有限公司
Publication of WO2017140017A1 publication Critical patent/WO2017140017A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A61M35/006—Portable hand-held applicators having means for dispensing or spreading integral media using sponges, foams, absorbent pads or swabs as spreading means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads

Definitions

  • the utility model relates to a wound first aid device, in particular to a wound hemostasis device with repeated drug application functions.
  • Bandages are materials used to secure and protect the wound. Ordinary bandages come in a variety of styles. The simplest one is a single shed, made of gauze or cotton, for the limbs, tail, head and chest and abdomen. The other is a complex bandage, which can be made into various shapes according to the body part and shape. The material is a double-layer cotton cloth, and cotton of different thickness can be sandwiched between the double-layer cotton cloths, and a cloth strip is arranged around the knot so as to be knotted and fixed, such as an eye. Bandages, back waist bandages, front chest bandages, abdominal bandages, etc.
  • the above-mentioned bandage is only suitable for dressing and hemostasis. Further, after the above bandage is used, the user cannot apply the wound to the wound covered by the bandage without tearing off the bandage. Specifically, if the user needs to re-apply the wound, the above bandage needs to be torn off, which will cause secondary damage to the wound, which is not conducive to the recovery of the wound.
  • the main purpose of the utility model is to provide a wound hemostasis device with repeated drug application functions, which aims to solve the product defect that the ordinary bandage cannot repeatedly apply to the human wound.
  • the present invention provides a wound hemostasis device having a repeated drug-applying function, wherein the wound hemostasis device having a repeated drug-applying function comprises a control unit, a hemostatic bandage and a connecting tube, wherein:
  • the control unit includes a hemostatic agent storage portion and a hemostatic agent propulsion portion, and the hemostatic agent storage portion is connected to the hemostatic agent propulsion portion;
  • the hemostatic bandage includes a bandage body and a hemostatic agent introduction tube, and the hemostatic agent introduction tube is disposed in the bandage body;
  • the hemostatic agent pushing portion and the hemostatic agent introduction tube are connected by the communication tube;
  • the hemostatic agent storage portion is for containing a hemostatic agent
  • the hemostatic agent advancement portion is configured to advance the hemostatic agent into the hemostatic agent introduction tube through the communication tube;
  • the surface of the hemostatic agent introduction tube is provided with a plurality of circular holes for introducing the hemostatic agent onto a human wound.
  • the hemostatic agent is a blood agent particle; the hemostatic agent advancing portion is a micro fan for blowing the hemostatic agent particles into the hemostatic agent introduction tube.
  • the hemostatic agent is a blood agent liquid; the hemostatic agent advancing portion is a syringe for injecting the hemostatic agent liquid into the hemostatic agent introduction tube.
  • the bandage body is a breathable medical tape.
  • the hemostatic agent introduction tube is disposed on the adhesive surface of the bandage body, and the adhesive surface is provided with a medical adhesive.
  • the hemostatic agent introduction tube is a hollow glass tube or a hollow medical rubber tube.
  • the connecting tube is a detachable structure.
  • control unit includes N hemostatic agent advancement portions, and the hemostatic bandage includes N hemostatic agent introduction tubes, wherein each hemostatic agent advancement portion is respectively connected to a corresponding one of the hemostatic agent introduction tubes.
  • the wound hemostasis device with repeated drug application functions of the present invention adopts the above technical solution, and achieves the following technical effects: the wound hemostasis device can repeatedly apply medicine to human body wounds, and timely to the human body Hemostasis in the wound is conducive to the recovery of the wound, avoiding secondary damage caused by the drug again, and speeding up the healing of the human wound.
  • FIG. 1 is a schematic structural view of a first embodiment of a wound hemostasis device having a repeated drug application function according to the present invention
  • FIG. 2 is a schematic view showing the structure of a second embodiment of the wound hemostasis device with repeated drug application functions of the present invention.
  • FIG. 1 is a schematic plan view showing a preferred embodiment of a wound hemostatic device having a repeated drug application function according to the present invention.
  • the wound hemostasis device 100 having a repeated drug application function includes, but is not limited to, a control unit 1, a hemostatic bandage 2, and a communication tube 3, and the control unit 1 and the hemostatic bandage 2 pass through the communication tube. 3 connections.
  • the control unit 1 includes, but is not limited to, a hemostatic agent storage unit 10 and a hemostatic agent advancement unit 12, and the hemostatic agent storage unit 10 is connected to the hemostatic agent advancement unit 12.
  • the hemostatic bandage 2 includes, but is not limited to, a bandage body 20 and a hemostatic agent introduction tube 22, and the hemostatic agent introduction tube 22 is disposed in the bandage body 20.
  • the hemostatic agent pushing unit 12 and the hemostatic agent introduction tube 20 are connected by a communication tube 3.
  • the communication tube 3 is a detachable structure.
  • the hemostatic agent storage portion 10 is for containing a hemostatic agent, and the hemostatic agent may be a hemostatic agent particle or a hemostatic agent liquid.
  • the hemostatic agent particles are nano-sized porous calcium carbonate hemostatic particles (ie, the hemostatic agent is encapsulated in the calcium carbonate shell), when the nano-scale porous calcium carbonate hemostatic particles are in contact with blood At the time, the organic acid in the blood chemically reacts with the calcium carbonate shell of the nanoporous calcium carbonate hemostatic particles to generate carbon dioxide bubbles, which push the hemostatic agent particles deep into the blood vessel to enhance the hemostatic effect.
  • the hemostatic agent pushing unit 12 is configured to advance the hemostatic agent in the hemostatic agent storage unit 10 into the hemostatic agent introduction tube 22 through the communication tube 3.
  • the hemostatic agent propelling unit 12 is a micro fan that blows the hemostatic agent in the hemostatic agent storage unit 10 into the hemostatic agent.
  • the bandage body 20 is a gas permeable medical tape, such that the gas blown into the hemostatic agent introduction tube 22 is dissipated through the gas permeable medical tape, and the hemostatic agent flows in the bandage body 20 to the human body wound. Stop bleeding.
  • the hemostatic agent advancing portion 12 is a syringe for injecting the hemostatic agent liquid into the hemostatic agent introduction tube.
  • the hemostatic agent introduction tube 22 is provided on the attachment surface of the bandage body 20.
  • the adhesive surface is provided with a medical adhesive so that the bandage body 20 can be attached to the skin of the human body without falling off.
  • the hemostatic agent introduction tube 22 may be located at any position on the attachment surface of the bandage body 20 (as long as the bandage body 20 can completely cover the hemostatic agent introduction tube 22).
  • the shape of the bandage body 20 may be, but not limited to, a rectangle, a square, a circle, or the like.
  • the hemostatic agent introduction tube 22 is located at an intermediate position of the bandage body 20 such that when the bandage body 20 is attached to the wound, the hemostatic agent introduction tube 22 is located at the position of the wound (or the wound is the most Severe area).
  • a plurality of circular holes 24 are formed in the surface of the hemostatic agent introduction tube 22, and a hemostatic agent that enters the hemostatic agent introduction tube 22 is introduced into the human wound through the circular hole 24.
  • the hemostatic agent introduction tube 22 may be, but not limited to, a hollow glass tube or a hollow medical rubber tube. Since the hemostatic agent introduction tube 22 is disposed in the hemostatic bandage 2, the user can push the hemostatic agent into the human wound multiple times to stop bleeding on the human wound.
  • control unit 1 includes N hemostatic agent advancement portions 12, and the hemostatic bandage 2 includes N hemostatic agent introduction tubes 22, wherein each hemostatic agent advancement portion 12 passes through a communication tube 3, respectively. It is connected to a hemostatic agent introduction tube 22 to stop bleeding for wounds at various locations in the human wound.
  • control unit 1 includes two hemostatic agent advancement portions 12, and the hemostatic bandage 2 includes two hemostatic agent introduction tubes 22, wherein a hemostatic agent advancement portion 12 is passed through a communication tube 3 A hemostatic agent introduction tube 22 is connected.

Abstract

A wound hemostatic device having a repeated drug administration function (100), comprising a control unit (1), a tourniquet bandage (2), and a connection tube (3). The control unit (1) comprises a hemostatic agent storage portion (10) and a hemostatic agent driving portion (12). The tourniquet bandage (2) comprises a bandage body (20) and a hemostatic agent guide tube (22). The hemostatic agent driving portion (12) and the hemostatic agent guide tube (22) are connected by means of the connection tube (3). The hemostatic agent storage portion (10) is used for holding a hemostatic agent. The hemostatic agent driving portion (12) is used for driving the hemostatic agent to the hemostatic agent guide tube (22) by means of the connection tube (3). The surface of the hemostatic agent guide tube (22) is provided with a plurality of circular holes (24). The circular holes are used for guiding the hemostatic agent to a wound on a human body. The present hemostatic device can repeatedly administer drug to a wound, thereby stopping bleeding in a timely manner and accelerating the rate of healing of the wound.

Description

具有反复上药功能的伤口止血装置  Wound hemostasis device with repeated drug application
技术领域Technical field
本实用新型涉及伤口急救装备，尤其涉及一种具有反复上药功能的伤口止血装置。The utility model relates to a wound first aid device, in particular to a wound hemostasis device with repeated drug application functions.
背景技术Background technique
绷带是用以固定和保护伤口的材料。普通绷带有多种类型，最简单的一种是单棚带，由纱布或棉布制成，适用于四肢、尾部、头部以及胸腹部。另一种是复绷带，可以按照身体部位和形状而制成各种形状，材料为双层棉布，双层棉布之间可夹不同厚度的棉花，周边有布条，以便打结固定，如眼绷带、背腰绷带、前胸绷带、腹绷带等。Bandages are materials used to secure and protect the wound. Ordinary bandages come in a variety of styles. The simplest one is a single shed, made of gauze or cotton, for the limbs, tail, head and chest and abdomen. The other is a complex bandage, which can be made into various shapes according to the body part and shape. The material is a double-layer cotton cloth, and cotton of different thickness can be sandwiched between the double-layer cotton cloths, and a cloth strip is arranged around the knot so as to be knotted and fixed, such as an eye. Bandages, back waist bandages, front chest bandages, abdominal bandages, etc.
然而，上述绷带仅仅适用于包扎止血作用，进一步地，上述绷带使用之后，用户在不撕掉绷带的情况下，无法对绷带所覆盖的伤口上药。具体地说，若用户需要对伤口再次上药，需要将上述绷带撕掉，如此会造成伤口的二次伤害，不利于伤口的恢复。However, the above-mentioned bandage is only suitable for dressing and hemostasis. Further, after the above bandage is used, the user cannot apply the wound to the wound covered by the bandage without tearing off the bandage. Specifically, if the user needs to re-apply the wound, the above bandage needs to be torn off, which will cause secondary damage to the wound, which is not conducive to the recovery of the wound.
实用新型内容Utility model content
本实用新型的主要目的在于提供一种具有反复上药功能的伤口止血装置，旨在解决普通绷带无法反复对人体伤口上药的产品缺陷。The main purpose of the utility model is to provide a wound hemostasis device with repeated drug application functions, which aims to solve the product defect that the ordinary bandage cannot repeatedly apply to the human wound.
为实现上述目的，本实用新型提供了一种具有反复上药功能的伤口止血装置，所述具有反复上药功能的伤口止血装置包括控制单元、止血绷带及连通管，其中：In order to achieve the above object, the present invention provides a wound hemostasis device having a repeated drug-applying function, wherein the wound hemostasis device having a repeated drug-applying function comprises a control unit, a hemostatic bandage and a connecting tube, wherein:
所述控制单元包括止血剂储存部及止血剂推进部，所述止血剂储存部与所述止血剂推进部连接；The control unit includes a hemostatic agent storage portion and a hemostatic agent propulsion portion, and the hemostatic agent storage portion is connected to the hemostatic agent propulsion portion;
所述止血绷带包括绷带本体及止血剂导入管，所述止血剂导入管设置于所述绷带本体内；The hemostatic bandage includes a bandage body and a hemostatic agent introduction tube, and the hemostatic agent introduction tube is disposed in the bandage body;
所述止血剂推进部与所述止血剂导入管之间通过所述连通管连接；The hemostatic agent pushing portion and the hemostatic agent introduction tube are connected by the communication tube;
所述止血剂储存部用于盛装止血剂；The hemostatic agent storage portion is for containing a hemostatic agent;
所述止血剂推进部用于将所述止血剂通过所述连通管推进至所述止血剂导入管中；及The hemostatic agent advancement portion is configured to advance the hemostatic agent into the hemostatic agent introduction tube through the communication tube; and
所述止血剂导入管的表面设置多个圆孔，所述圆孔用于将所述止血剂导入至人体伤口上。The surface of the hemostatic agent introduction tube is provided with a plurality of circular holes for introducing the hemostatic agent onto a human wound.
优选的，所述止血剂为止血剂颗粒；所述止血剂推进部为微型风扇，用于将所述止血剂颗粒吹入所述止血剂导入管中。Preferably, the hemostatic agent is a blood agent particle; the hemostatic agent advancing portion is a micro fan for blowing the hemostatic agent particles into the hemostatic agent introduction tube.
优选的，所述止血剂为止血剂液体；所述止血剂推进部为注射器，用于将所述止血剂液体注入至所述止血剂导入管中。Preferably, the hemostatic agent is a blood agent liquid; the hemostatic agent advancing portion is a syringe for injecting the hemostatic agent liquid into the hemostatic agent introduction tube.
优选的，所述绷带本体为透气医用胶布。Preferably, the bandage body is a breathable medical tape.
优选的，所述止血剂导入管设置于绷带本体的粘贴面，所述粘贴面上设置有医用粘胶。Preferably, the hemostatic agent introduction tube is disposed on the adhesive surface of the bandage body, and the adhesive surface is provided with a medical adhesive.
优选的，所述止血剂导入管是空心玻璃管或空心医用橡胶管。Preferably, the hemostatic agent introduction tube is a hollow glass tube or a hollow medical rubber tube.
优选的，所述连通管为可拆卸结构。Preferably, the connecting tube is a detachable structure.
优选的，所述控制单元包括N个止血剂推进部，所述止血绷带包括N个止血剂导入管，其中，每个止血剂推进部分别与对应的一个止血剂导入管连接。Preferably, the control unit includes N hemostatic agent advancement portions, and the hemostatic bandage includes N hemostatic agent introduction tubes, wherein each hemostatic agent advancement portion is respectively connected to a corresponding one of the hemostatic agent introduction tubes.
相较于现有技术，本实用新型所述具有反复上药功能的伤口止血装置采用了上述技术方案，达到了如下技术效果：所述伤口止血装置能够对人体的伤口反复上药，及时对人体伤口止血，有利于伤口的恢复，避免再次上药对人体伤口造成二次伤害，加快了人体伤口的治愈速度。Compared with the prior art, the wound hemostasis device with repeated drug application functions of the present invention adopts the above technical solution, and achieves the following technical effects: the wound hemostasis device can repeatedly apply medicine to human body wounds, and timely to the human body Hemostasis in the wound is conducive to the recovery of the wound, avoiding secondary damage caused by the drug again, and speeding up the healing of the human wound.
附图说明DRAWINGS
图1是本实用新型具有反复上药功能的伤口止血装置第一实施例的结构示意图；1 is a schematic structural view of a first embodiment of a wound hemostasis device having a repeated drug application function according to the present invention;
图2是本实用新型具有反复上药功能的伤口止血装置第二实施例的结构示意图。2 is a schematic view showing the structure of a second embodiment of the wound hemostasis device with repeated drug application functions of the present invention.
本实用新型目的的实现、功能特点及优点将结合实施例，参照附图做进一步说明。The implementation, functional features and advantages of the present invention will be further described with reference to the accompanying drawings.
具体实施方式detailed description
为更进一步阐述本实用新型为达成上述目的所采取的技术手段及功效，以下结合附图及较佳实施例，对本实用新型的具体实施方式、结构、特征及其功效进行详细说明。应当理解，本实用新型所描述的具体实施例仅仅用以解释本实用新型，并不用于限定本实用新型。The specific embodiments, structures, features and functions of the present invention will be described in detail below with reference to the accompanying drawings and preferred embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
如图1所示，图1是本实用新型具有反复上药功能的伤口止血装置较佳实施例的平面结构示意图。As shown in FIG. 1, FIG. 1 is a schematic plan view showing a preferred embodiment of a wound hemostatic device having a repeated drug application function according to the present invention.
在本实施例中，所述具有反复上药功能的伤口止血装置100包括，但不限于，控制单元1、止血绷带2及连通管3，所述控制单元1与所述止血绷带2通过连通管3连接。In the present embodiment, the wound hemostasis device 100 having a repeated drug application function includes, but is not limited to, a control unit 1, a hemostatic bandage 2, and a communication tube 3, and the control unit 1 and the hemostatic bandage 2 pass through the communication tube. 3 connections.
所述控制单元1包括，但不限于，止血剂储存部10及止血剂推进部12，所述止血剂储存部10与所述止血剂推进部12连接。The control unit 1 includes, but is not limited to, a hemostatic agent storage unit 10 and a hemostatic agent advancement unit 12, and the hemostatic agent storage unit 10 is connected to the hemostatic agent advancement unit 12.
所述止血绷带2包括，但不限于，绷带本体20及止血剂导入管22，所述止血剂导入管22设置于所述绷带本体20内。The hemostatic bandage 2 includes, but is not limited to, a bandage body 20 and a hemostatic agent introduction tube 22, and the hemostatic agent introduction tube 22 is disposed in the bandage body 20.
所述止血剂推进部12与所述止血剂导入管20之间通过连通管3连接。The hemostatic agent pushing unit 12 and the hemostatic agent introduction tube 20 are connected by a communication tube 3.
在本实施例中，所述连通管3为可拆卸结构。In this embodiment, the communication tube 3 is a detachable structure.
在控制单元1中，所述止血剂储存部10用于盛装止血剂，所述止血剂可以是止血剂颗粒，也可以是止血剂液体。In the control unit 1, the hemostatic agent storage portion 10 is for containing a hemostatic agent, and the hemostatic agent may be a hemostatic agent particle or a hemostatic agent liquid.
此外，若所述止血剂为止血剂颗粒时，所述止血剂颗粒为纳米级多孔碳酸钙止血颗粒（即止血剂包裹于碳酸钙外壳内），当该纳米级多孔碳酸钙止血颗粒与血液接触时，血液中的有机酸和该纳米级多孔碳酸钙止血颗粒的碳酸钙外壳发生化学反应，生成二氧化碳气泡，所述二氧化碳气泡推动止血剂微粒向血管深处推进，增强止血效果。In addition, if the hemostatic agent is a blood granule, the hemostatic agent particles are nano-sized porous calcium carbonate hemostatic particles (ie, the hemostatic agent is encapsulated in the calcium carbonate shell), when the nano-scale porous calcium carbonate hemostatic particles are in contact with blood At the time, the organic acid in the blood chemically reacts with the calcium carbonate shell of the nanoporous calcium carbonate hemostatic particles to generate carbon dioxide bubbles, which push the hemostatic agent particles deep into the blood vessel to enhance the hemostatic effect.
所述止血剂推进部12用于将所述止血剂储存部10中的止血剂通过连通管3推进至所述止血剂导入管22中。The hemostatic agent pushing unit 12 is configured to advance the hemostatic agent in the hemostatic agent storage unit 10 into the hemostatic agent introduction tube 22 through the communication tube 3.
需要说明的是，若所述止血剂为止血剂颗粒时，所述止血剂推进部12为微型风扇，所述微型风扇将所述止血剂储存部10中的止血剂吹入所述止血剂导入管22中。此外，所述绷带本体20为透气医用胶布，使得吹入所述止血剂导入管22中的气体通过透气医用胶布散出，而所述止血剂流在所述绷带本体20中，以对人体伤口止血。In the case of the blood granules of the hemostatic agent, the hemostatic agent propelling unit 12 is a micro fan that blows the hemostatic agent in the hemostatic agent storage unit 10 into the hemostatic agent. In tube 22. In addition, the bandage body 20 is a gas permeable medical tape, such that the gas blown into the hemostatic agent introduction tube 22 is dissipated through the gas permeable medical tape, and the hemostatic agent flows in the bandage body 20 to the human body wound. Stop bleeding.
若所述止血剂为液体止血剂时，所述止血剂推进部12为注射器，所述注射器用于将所述止血剂液体注入至所述止血剂导入管中。When the hemostatic agent is a liquid hemostatic agent, the hemostatic agent advancing portion 12 is a syringe for injecting the hemostatic agent liquid into the hemostatic agent introduction tube.
在所述止血绷带2中，所述止血剂导入管22设置于绷带本体20的粘贴面。该粘贴面上设置有医用粘胶，使得绷带本体20能够粘贴于人体的皮肤而不脱落。所述止血剂导入管22可以位于绷带本体20的粘贴面的任意位置（只要所述绷带本体20能够完全覆盖所述止血剂导入管22即可）。In the hemostatic bandage 2, the hemostatic agent introduction tube 22 is provided on the attachment surface of the bandage body 20. The adhesive surface is provided with a medical adhesive so that the bandage body 20 can be attached to the skin of the human body without falling off. The hemostatic agent introduction tube 22 may be located at any position on the attachment surface of the bandage body 20 (as long as the bandage body 20 can completely cover the hemostatic agent introduction tube 22).
所述绷带本体20的形状可以是，但不限于，长方形、正方形、圆形等。在本实施例中，所述止血剂导入管22位于所述绷带本体20的中间位置，使得绷带本体20粘贴于伤口时，所述止血剂导入管22正好位于伤口的位置（或者说，伤口最严重的区域）。The shape of the bandage body 20 may be, but not limited to, a rectangle, a square, a circle, or the like. In the present embodiment, the hemostatic agent introduction tube 22 is located at an intermediate position of the bandage body 20 such that when the bandage body 20 is attached to the wound, the hemostatic agent introduction tube 22 is located at the position of the wound (or the wound is the most Severe area).
所述止血剂导入管22的表面设置多个圆孔24，进入所述止血剂导入管22中的止血剂，通过所述圆孔24导入至人体伤口中。A plurality of circular holes 24 are formed in the surface of the hemostatic agent introduction tube 22, and a hemostatic agent that enters the hemostatic agent introduction tube 22 is introduced into the human wound through the circular hole 24.
所述止血剂导入管22可以是，但不限于，空心玻璃管或空心医用橡胶管。由于所述止血剂导入管22设置于所述止血绷带2中，用户可以多次为将止血剂推进至人体伤口中，以对人体伤口止血。The hemostatic agent introduction tube 22 may be, but not limited to, a hollow glass tube or a hollow medical rubber tube. Since the hemostatic agent introduction tube 22 is disposed in the hemostatic bandage 2, the user can push the hemostatic agent into the human wound multiple times to stop bleeding on the human wound.
此外，在其它实施例中，所述控制单元1包括N个止血剂推进部12，所述止血绷带2包括N个止血剂导入管22，其中每个止血剂推进部12分别通过一个连通管3与一个止血剂导入管22连接，以在人体伤口的多个位置为伤口止血。例如，如图2所示，所述控制单元1包括两个止血剂推进部12，所述止血绷带2包括两个止血剂导入管22，其中，一个止血剂推进部12通过一个连通管3与一个止血剂导入管22连接。Further, in other embodiments, the control unit 1 includes N hemostatic agent advancement portions 12, and the hemostatic bandage 2 includes N hemostatic agent introduction tubes 22, wherein each hemostatic agent advancement portion 12 passes through a communication tube 3, respectively. It is connected to a hemostatic agent introduction tube 22 to stop bleeding for wounds at various locations in the human wound. For example, as shown in FIG. 2, the control unit 1 includes two hemostatic agent advancement portions 12, and the hemostatic bandage 2 includes two hemostatic agent introduction tubes 22, wherein a hemostatic agent advancement portion 12 is passed through a communication tube 3 A hemostatic agent introduction tube 22 is connected.
以上仅为本实用新型的优选实施例，并非因此限制本实用新型的专利范围，凡是利用本实用新型说明书及附图内容所作的等效结构或等效功能变换，或直接或间接运用在其他相关的技术领域，均同理包括在本实用新型的专利保护范围内。The above is only a preferred embodiment of the present invention, and is not intended to limit the scope of the patents of the present invention. Any equivalent structure or equivalent function transformation made by the description of the present invention and the contents of the drawings may be directly or indirectly applied to other related The technical fields are all included in the scope of patent protection of the present invention.

Claims (8)

  1. 一种具有反复上药功能的伤口止血装置，其特征在于，所述具有反复上药功能的伤口止血装置包括控制单元、止血绷带及连通管，其中： A wound hemostasis device with repeated drug application function, characterized in that the wound hemostasis device with repeated drug application functions comprises a control unit, a hemostatic bandage and a connecting tube, wherein:
    所述控制单元包括止血剂储存部及止血剂推进部，所述止血剂储存部与所述止血剂推进部连接；The control unit includes a hemostatic agent storage portion and a hemostatic agent propulsion portion, and the hemostatic agent storage portion is connected to the hemostatic agent propulsion portion;
    所述止血绷带包括绷带本体及止血剂导入管，所述止血剂导入管设置于所述绷带本体内；The hemostatic bandage includes a bandage body and a hemostatic agent introduction tube, and the hemostatic agent introduction tube is disposed in the bandage body;
    所述止血剂推进部与所述止血剂导入管之间通过所述连通管连接；The hemostatic agent pushing portion and the hemostatic agent introduction tube are connected by the communication tube;
    所述止血剂储存部用于盛装止血剂；The hemostatic agent storage portion is for containing a hemostatic agent;
    所述止血剂推进部用于将所述止血剂通过所述连通管推进至所述止血剂导入管中；及The hemostatic agent advancement portion is configured to advance the hemostatic agent into the hemostatic agent introduction tube through the communication tube; and
    所述止血剂导入管的表面设置多个圆孔，所述圆孔用于将所述止血剂导入至人体伤口上。The surface of the hemostatic agent introduction tube is provided with a plurality of circular holes for introducing the hemostatic agent onto a human wound.
  2. 如权利要求1所述的具有反复上药功能的伤口止血装置，其特征在于，所述止血剂为止血剂颗粒；所述止血剂推进部为微型风扇，用于将所述止血剂颗粒吹入所述止血剂导入管中。A wound hemostatic device having a repeated drug administration function according to claim 1, wherein said hemostatic agent is a blood agent particle; said hemostatic agent advancing portion is a micro fan for blowing said hemostatic agent particles The hemostatic agent is introduced into the tube.
  3. 如权利要求1所述的具有反复上药功能的伤口止血装置，其特征在于，所述止血剂为止血剂液体；所述止血剂推进部为注射器，用于将所述止血剂液体注入至所述止血剂导入管中。A wound hemostatic device having a repeated drug administration function according to claim 1, wherein said hemostatic agent is a blood agent liquid; said hemostatic agent advancing portion is a syringe for injecting said hemostatic agent liquid into said The hemostatic agent is introduced into the tube.
  4. 如权利要求1所述的具有反复上药功能的伤口止血装置，其特征在于，所述绷带本体为透气医用胶布。A wound hemostasis device with a repeated drug application function according to claim 1, wherein the bandage body is a breathable medical tape.
  5. 如权利要求1所述的具有反复上药功能的伤口止血装置，其特征在于，所述止血剂导入管设置于绷带本体的粘贴面，所述粘贴面上设置有医用粘胶。The wound hemostatic device with a repeated drug application function according to claim 1, wherein the hemostatic agent introduction tube is disposed on a surface of the bandage body, and the adhesive surface is provided with a medical adhesive.
  6. 如权利要求1所述的具有反复上药功能的伤口止血装置，其特征在于，所述止血剂导入管是空心玻璃管或空心医用橡胶管。The wound hemostasis device with repeated drug application function according to claim 1, wherein the hemostatic agent introduction tube is a hollow glass tube or a hollow medical rubber tube.
  7. 如权利要求1所述的具有反复上药功能的伤口止血装置，其特征在于，所述连通管为可拆卸结构。 A wound hemostatic device having a repeated drug application function according to claim 1, wherein said communication tube is of a detachable structure.
  8. 如权利要求1所述的具有反复上药功能的伤口止血装置，其特征在于，所述控制单元包括N个止血剂推进部，所述止血绷带包括N个止血剂导入管，其中，每个止血剂推进部分别与对应的一个止血剂导入管连接。A wound hemostatic device having a repeated drug administration function according to claim 1, wherein said control unit comprises N hemostatic agent advancing portions, and said hemostatic bandage comprises N hemostatic agent introduction tubes, wherein each hemostasis The agent advancing portions are respectively connected to a corresponding one of the hemostatic agent introduction tubes.
PCT/CN2016/078241 2016-02-20 2016-04-01 Wound hemostatic device having repeated drug administration function WO2017140017A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201620132906.3U CN205434083U (en) 2016-02-20 2016-02-20 Wound hemostasis device with function of adding medicine to repeatedly
CN201620132906.3 2016-02-20

Publications (1)

Publication Number Publication Date
WO2017140017A1 true WO2017140017A1 (en) 2017-08-24

Family

ID=56581921

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/078241 WO2017140017A1 (en) 2016-02-20 2016-04-01 Wound hemostatic device having repeated drug administration function

Country Status (2)

Country Link
CN (1) CN205434083U (en)
WO (1) WO2017140017A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113397831A (en) * 2021-07-21 2021-09-17 孙金香 Medicine feeding bandaging equipment for dermatological treatment

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11452641B2 (en) * 2019-06-28 2022-09-27 Ethicon, Inc. Wound closure systems for reducing surgical site infections comprising incision drapes filled with releasable antimicrobial agents

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089168A (en) * 1992-10-30 1994-07-13 梅地普洛科学有限公司 The material delivery systems of local application
US20060100586A1 (en) * 2004-11-08 2006-05-11 Boehringer Laboratories, Inc. Tube attachment device for wound treatment
CN1874801A (en) * 2003-10-28 2006-12-06 史密夫及内修公开有限公司 Wound cleansing apparatus with actives
WO2007128985A2 (en) * 2006-04-06 2007-11-15 Insense Limited Skin dressing
CN101257875A (en) * 2005-09-06 2008-09-03 泰科保健集团有限合伙公司 Self contained wound dressing with micropump
CN101389299A (en) * 2006-01-09 2009-03-18 杰克·曼特科 Hemostatic agent delivery system

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089168A (en) * 1992-10-30 1994-07-13 梅地普洛科学有限公司 The material delivery systems of local application
CN1874801A (en) * 2003-10-28 2006-12-06 史密夫及内修公开有限公司 Wound cleansing apparatus with actives
US20060100586A1 (en) * 2004-11-08 2006-05-11 Boehringer Laboratories, Inc. Tube attachment device for wound treatment
CN101257875A (en) * 2005-09-06 2008-09-03 泰科保健集团有限合伙公司 Self contained wound dressing with micropump
CN101389299A (en) * 2006-01-09 2009-03-18 杰克·曼特科 Hemostatic agent delivery system
WO2007128985A2 (en) * 2006-04-06 2007-11-15 Insense Limited Skin dressing

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113397831A (en) * 2021-07-21 2021-09-17 孙金香 Medicine feeding bandaging equipment for dermatological treatment

Also Published As

Publication number Publication date
CN205434083U (en) 2016-08-10

Similar Documents

Publication Publication Date Title
CN106456569B (en) Device for delivering skin care compositions
RU2711863C2 (en) Two-component wound dressing system
WO2015135351A1 (en) Liquid-absorption wound dressing helping to observe wound surface
RU2704601C2 (en) Wound dressing system
WO2017140017A1 (en) Wound hemostatic device having repeated drug administration function
CN208081398U (en) A kind of first-aid kit of medical article
CN107441612A (en) Umbilical cord arteriovenous puts pipe novel bridge type fixation
CN209107788U (en) A kind of hemostatic dressing plaster
CN206995399U (en) Disposable eye patch is auxiliary
CN205515183U (en) Be full of cracks of prevention and cure lying -in woman nipple is pasted
CN209269786U (en) Air bag for nasal cavity is used in a kind of nursing
CN103099708A (en) Gapless-fixing-type wound dressing
CN216876812U (en) Wrap convenient aseptic applying ointment or plaster
CN219480597U (en) Filling type adhesive bandage with medicament
CN208525232U (en) One kind changeing convenient newborn with permanent magnetism navel protective cord
CN201684078U (en) Navel paster
CN215019851U (en) Anorectal postoperative dressing change assistor
CN203234899U (en) Gapless fixing type wound dressing
CN212816758U (en) Dressing for venous indwelling needle
CN206239559U (en) Neonatal umbilical cord bag
CN213641571U (en) Novel hemostatic and anti-inflammatory medical dressing
CN213722909U (en) Thigh postoperative wound resumes to apply area
CN219941005U (en) Medical high air permeability is applied ointment or plaster
CN216676120U (en) Medical autogenous cutting nursing antibacterial pad
CN215994493U (en) Gynaecology and obstetrics is with wound nursing device postpartum

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16890250

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16890250

Country of ref document: EP

Kind code of ref document: A1